Related Experiment Videos
Identification of the Syrian hamster cardiomyopathy gene
V Nigro1, Y Okazaki, A Belsito
1Istituto di Patologia Generale e Oncologia, Facolta di Medicina, Seconda Università degli Studi di Napoli, Italy.
Insights
Researchers identified a mutation in the delta-sarcoglycan gene as the cause of a genetic defect leading to cardiomyopathy in BIO14.6 hamsters. This discovery provides the first animal model for human sarcoglycan disorders.
Area of Science:
- Cardiovascular Research
- Genetics
- Animal Models
Background:
- The BIO14.6 hamster is a common model for studying autosomal recessive cardiomyopathy.
- These hamsters experience premature death due to progressive myocardial necrosis and heart failure.
- The specific genetic cause of this cardiomyopathy has remained unidentified.
Purpose of the Study:
- To identify the genetic mutation responsible for cardiomyopathy in BIO14.6 hamsters.
- To confirm the identified gene's location within the previously mapped cardiomyopathy locus.
Main Methods:
- Genetic linkage mapping was used to localize the cardiomyopathy locus.
- Candidate genes within the locus were investigated.
- Genetic analysis of backcross and F2 pedigrees was performed to confirm the mutation's association with the disease.
Main Results:
- A mutation in the delta-sarcoglycan gene was identified as the cause of the cardiomyopathy.
- The delta-sarcoglycan gene was found to map precisely to the disease locus on hamster chromosome 9qa2.1-b1.
- The identified mutation showed complete coincidence with the disease phenotype in genetic crosses.
Conclusions:
- The study successfully identified the genetic basis of cardiomyopathy in BIO14.6 hamsters.
- This research establishes the BIO14.6 hamster as the first animal model for human sarcoglycan disorders.
- This model will be valuable for investigating the mechanisms and potential treatments for sarcoglycanopathies.
Abstract:
The BIO14.6 hamster is a widely used model for autosomal recessive cardiomyopathy. These animals die prematurely from progressive myocardial necrosis and heart failure. The primary genetic defect leading to the cardiomyopathy is still unknown. Recently, a genetic linkage map localized the cardiomyopathy locus on hamster chromosome 9qa2.1-b1, excluding several candidate genes. We now demonstrate that the cardiomyopathy results from a mutation in the delta-sarcoglycan gene that maps to the disease locus. This mutation was completely coincident with the disease in backcross and F2 pedigrees. This constitutes the first animal model identified for human sarcoglycan disorders.